LIVER DISEASES

69
LIVER DISEASES

description

LIVER DISEASES. Physiology of liver. Liver is the largest organ of the body. Sets in the right side of the belly. Weighs between 1.0-2.5 kg. Heavier in males than females. It is reddish in color & feel rubbery to touch. Have two sections-right & left lobe. - PowerPoint PPT Presentation

Transcript of LIVER DISEASES

Page 1: LIVER DISEASES

LIVER DISEASES

Page 2: LIVER DISEASES

PHYSIOLOGY OF LIVER Liver is the largest organ of

the body. Sets in the right side of the

belly. Weighs between 1.0-2.5 kg. Heavier in males than

females. It is reddish in color & feel

rubbery to touch. Have two sections-right &

left lobe. The right lobe is further

divided into the interior and posterior segments

Page 3: LIVER DISEASES

The externally visible falciform ligament divides the left lobe into the medial and

lateral segments. Liver is supplied with blood from two sources –

the hepatic artery & portal vein. Responsible for 25 %of the basal metabolism

& intimately concerned with the metabolism of fats,protiens & CHO.

Shortcut to img_illust_normalLiver_en[1].lnk

Page 4: LIVER DISEASES
Page 5: LIVER DISEASES

STRUCTURE OF LIVER

Composed of 50,000-100,000 lobules.

Each lobule consist of a central vein surrounded by tiny liver cells grouped in the sheet or bundle.

Small branch of hepatic vein extends through their centre. .

Space b/w these cells contain sinusoids (blood vessels that are irregular in shape, incomplete in size &wider than blood capillaries .)

Page 6: LIVER DISEASES
Page 7: LIVER DISEASES
Page 8: LIVER DISEASES

Page 9: LIVER DISEASES

BLOOD SUPPLY the liver receives blood containing oxygen from the heart.

This blood enters the liver through the hepatic artery. The liver also receives blood filled with nutrients, or

digested food particles, from the small intestine. This blood enters the liver through the portal vein.

In the liver, the hepatic artery and the portal vein branch into a network of tiny blood vessels that empty into the sinusoids.

The liver cells absorb nutrients and oxygen from the blood as it flows through the sinusoids. At the same time, they secrete sugar, vitamins, minerals, and other substances into the blood.

The sinusoids drain into the central veins, which join to form the hepatic vein. Blood leaves the liver through the hepatic vein.

Each lobule also contains bile capillaries, tiny tubes that carry the bile secreted by the liver cells. The bile capillaries join to form bile ducts, which carry bile out of the liver. Soon after leaving the liver, the bile ducts join together, forming the hepatic duct.

Excess bile flows into the gall bladder, where it is stored for later use.

Page 10: LIVER DISEASES

BLOOD SUPPLY

Page 11: LIVER DISEASES

FUNCTIONS OF LIVER1) Secretion of bile 2) Storage of glycogen3) Metabolism of fats4) Deamination of amino acids5) Production of the plasma protiens.6) Storage & transport of vitamins &

minerals.7) Storage of iron .8) Production of clotting factors .9) Production of heat .10) Detoxification.11) Acts as filter

Page 12: LIVER DISEASES

ROLE OF BRANCHED CHAIN AMINO ACIDS & AROMATIC AMINO ACIDS IN LIVER DISEASE

major hypothesis for the pathogenesis of portal systemic encephalopathy has been termed the altered neurotransmitter Theory.

A plasma amino acid imbalance existsin ESLD in which the branched-chain amino acids( BGAAs) valine, leucine, and isoleucine are decreased, and aromatic amino acids (AAAs) tryptophan, phenylalanine, and tryrosine,plus methionine, glutamine, asparagine, and histidine are increased.

The BCAAs furnish as much as 30% of energy requirements for skeletal muscle, heart, and brain when gluconeogenesis and ketogenesis are depressed .

This causes serum BCAA levels to fall. At the same time, plasma AAA’S and methionine are released into circulation by muscle proteolysis, but the synthesis into protein and liver clearance of AAAs is depressed .

This changes the plasma molar ratio of BCAAs to AAA’S and may contribute to the development of hepatic

encephalopathy. AAAs may limit the cerebral uptake of BCAA because they

compete for carrier-mediated transport at the blood-brain barrier...

Page 13: LIVER DISEASES

.

Amino Acids Commonly Altered in Liver DiseaseAromatic Amino Acids: serum levels are increased.

TyrosinePhenylalanine*Free tryptophan*

Branched €hain Amino Acids: levels are decreased.

Valine*Leucine"Isoleucine*Ammonlogenic Amino Acids: levels are increased.

GlycineSerineThreonine*GlutamineHistidine*Lysine"AsparagineMethionine*

Page 14: LIVER DISEASES
Page 15: LIVER DISEASES

1.ASPARTATE AMINOTRANSFERASE (AST OR SGOT)• Located in cytosol and mitochondria of hepatocyte also

in cardiac and skeletal muscle, brain, pancreas, kidney and leukocytes.

• An enzyme similar to ALT but less specific for liver disease.

• Levels of AST are increased with liver damage or death of hepatocytes.

• In some cases viz alcoholic hepatitis or shock liv the elevation in serum AST level may be, higher than the elevation in serum ALT level.

• AST Normal range – 2-40 U/L.

Page 16: LIVER DISEASES

2.ALANINE AMINOTRANSFERASE (ALT OR SGPT)• It is located in cytosol of hepatocytes found in several

other body tissues.• It is highest in liver.• ALT level is increased in case of liver cell death, caused

due to, Hepatitis, any shock, injury or excess alcohol or drug toxicity.

• Normal range – 2-40 U/L

Page 17: LIVER DISEASES

3.SERUM ALKALINE PHOSPHATASE• An enzyme that is widely distributed in liver, bone,

placenta, intestine, kidney, leukocytes.• It is mainly bound to canalicular membranes of liver

produced in the bile ducts.• This enzyme activity can be increased with bone

disorders, pregnancy , normal growth & some malignancies.

• 40 - 129 U/L

Page 18: LIVER DISEASES

4.BILIRUBIN Bilirubin is a yellow breakdown product

of the normal heme catabolism . It is excreted in bile & urine and

elevated levels may indicate certain diseases.

It is responsible for the yellow color of the bruises ,urine & brown color of feces & yellow discoloration of skin.

Page 19: LIVER DISEASES

FUNCTIONS Bilirubin is created by the activity

of biliverdin reductase on biliverdin, a green tetrapyrrolic bile pigment that is also a product of heme catabolism. Bilirubin, when oxidized, reverts to become biliverdin once again. This cycle, in addition to the demonstration of the potent antioxidant activity of bilirubin, has led to the hypothesis that bilirubin's main physiologic role is as a cellular antioxidant.

Page 20: LIVER DISEASES

TYPES OF BILIRUBIN Unconjugated bilirubin

(indirect) Erythrocytes (red blood cells)

generated in the bone marrow are disposed of in the spleen when they get old or damaged. This releases hemoglobin, which is broken down to heme as the globin parts are turned into amino acids. The heme is then turned into unconjugated bilirubin in the reticuloendothelial cells of the spleen. This unconjugated bilirubin is not soluble in water, due to intramolecular hydrogen bonding. It is then bound to albumin and sent to the liver

Conjugated bilirubin(direct) In the liver it is conjugated with 

glucuronic acid by the enzyme glucuronyltransferase, making it soluble in water. Much of it goes into the bile and thus out into the small intestine. However 95% of the secreted bile is reabsorbed by the small intestine. This bile is then resecreted by the liver into the small intestine. This process is known as enterohepatic circulation. About half of the conjugated bilirubin remaining in the large intestine(about 5% of what was originally secreted) is metabolized by colonic bacteria to urobilinogen, which can be further metabolized to stercobilinogen, and finally oxidized to stercobilin. Stercobilin gives feces its brown color

Page 21: LIVER DISEASES

BLOOD TESTS Bilirubin is broken down by light. Tubes

containing blood or (especially) serum to be used in bilirubin assays should be protected from illumination.

Total bilirubin ("TBIL") measures both BU and BC. Total and direct bilirubin levels can be measured from the blood, but indirect bilirubin is calculated from the total and direct bilirubin.

Indirect bilirubin is fat-soluble and direct bilirubin is water-soluble.

Bilirubin (in blood) is in two forms.

Page 22: LIVER DISEASES

BLOOD TESTS

Abb. Name(s) Water-soluble? Reaction

"BC" "Conjugated" or"Direct bilirubin"

Yes (bound toglucuronic acid)

Reacts quickly when dyes (diazo reagent) are added to the blood specimen to produceazobilirubin "Direct bilirubin"

"BU" "Unconjugated" or "Indirect bilirubin" No

Reacts more slowly. Still produces azobilirubin. Ethanol makes all bilirubin react promptly then calc: Indirect bilirubin = Total bilirubin - Direct bilirubin

Page 23: LIVER DISEASES

NORMAL RANGES OF BILIRUBIN IN BLOOD -μmol/L mg/dL

0.2-1.9,[

Total bilirubin 5.1–17.0 0.3–1.0

0.1-1.2

Direct bilirubin 1.0–5.1 0-0.3

0.1–0.3

0.1-0.4

Page 24: LIVER DISEASES

HYPERBILIRUBINEMIA Hyperbilirubinemia results from a higher than normal level of bilirubin in the

blood. Mild rises in bilirubin may be caused by: Hemolysis or increased breakdown of red blood cells Gilbert's syndrome - a genetic disorder of bilirubin metabolism that can result in

mild jaundice, found in about 5% of the population Rotor syndrome: non-itching jaundice, with rise of bilirubin in the patient's

serum, mainly of the conjugated type. Moderate rise in bilirubin may be caused by: Pharmaceutical drugs (especially antipsychotic, some sex hormones, and a wide

range of other drugs) Sulfonamides are contraindicated in infants less than 2 months old as they

increase unconjugated bilirubin leading to kernicterus. Hepatitis (levels may be moderate or high) Chemotherapy Biliary stricture (benign or malignant) Very levels of bilirubin may be caused by: Neonatal hyperbilirubinaemia, where the newborn's liver is not able to properly

process the bilirubin causing jaundice Unusually large bile duct obstruction, e.g. stone in common bile duct, tumour

obstructing common bile duct etc. Severe liver failure with cirrhosis (e.g. primary biliary cirrhosis Choledocholithiasis (chronic or acute)presence of gallstone in the common

bile duct

Page 25: LIVER DISEASES

5.GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)• An enzyme associated with microsomes and plasma

membranes in hepatocytes also present in kidney, pancreas,

heart , brain.

• An enzyme produced in the bile ducts that like alkaline

phosphatase, may be elevated in the serum of patients with

bile duct disease.

• It is increased with liver disease, pulmonary disease, diabetes

mellitus and during alcohol ingestion by many drugs.

Page 26: LIVER DISEASES

SERUM ALBUMIN• Main export protein synthesized in the liver and most imp. factor in plasma

osmotic pressure maintenance, secreted in the blood.• Major protein circulating in blood stream.• Low serum albumin levels indicate poor liver function.• Serum albumin concentration is usually normal in chronic liver diseases until

cirrhosis and liver damage is present.

• Albumin – 3.4 - 4.8 g%.

• Albumin levels can be low in conditions other than, liver disease like

malnutrition.

• Albumin is a better index of chronic liver disease.

• Increased losses occur with protein losing enteropathy, nephrotic syndrome

burns, GIT bleeding, exfoliative dermatitis.

Page 27: LIVER DISEASES

PROTHROMBIN TIME• Most blood coagulation factors are synthesized in the liver.

• When liver function is severely abnormal, their synthesis and secretion into

blood is decreased.

• PT is a type of blood clotting test and is prolonged when blood

concentration of some clotting factors made by liver are low.

• In chronic liver disease, PT is not usually elevated until cirrhosis is present

and liver damage is significant.

• In acute liver disease, PT can be prolonged with severe liver damage.

• Decreased synthesis of clotting factors increase prothrombin time and risk

of bleeding.

Page 28: LIVER DISEASES

SERUM PROTEIN ELECTROPHORESIS• Major protein in the serum are separated in an electric

field and their concentrations are determined.• Four major types of serum proteins measured are

albumin, alpha- globulins, beta- globulins and gamma- globulins.

• Alpha and gamma globulins are synthesized in liver. Levels increase with chronic liver disease.

• In cirrhosis, the albumin may be decreased and the gamma - globulins elevated.

• Gamma- globulins can be significantly elevated in some types of autoimmune hepatitis also.

Page 29: LIVER DISEASES

PLATELET COUNT• Platelets are the smallest of the blood cells, involved in

blood clotting.• With liver disease the spleen becomes enlarged as

blood flow through the liver is impeded.• This can lead to platelets being sequestered in the

enlarged spleen.• The platelet count can be abnormal in many conditions

other than liver disease.

Page 30: LIVER DISEASES

GALL BLADDER DISEASES

Page 31: LIVER DISEASES

GALLBLADDER

It is a thin walled reservoir situated on the under surface of liver.

It can store about 40-50ml of bile.

It concentrates bile formed in the liver.

Stores it , until needed for digestion.

Interference with the flow of bile in gallbladder diseases may cause impaired fat digestion.

Page 32: LIVER DISEASES

FUNCTIONS OF GALL BLADDER Acts as a reservoir for the

storage of bile . Mucosal lining of gall

bladder reabsorbs the fluid & electrolytes ,thus concentrating the bile constituents.

Hormone cholecystokinin secreted by the duodenal walls, cause muscular walls of the gall bladder to contract and expel the bile.

Duodenal peristalsis inhibits the sphincter of oddi & cause it to relax & allow the bile to enter the duodenum.

Page 33: LIVER DISEASES

BILE Bile is the external secretion of the liver . Produced in the diluted form . Concentrated later by the gall bladder to a

viscid greenish fluid . It consists of- Water Bile salts(sodium glycocholate &sodium

taurocholate) Bile acids Bile pigment( bilirubin). Cholesterol Mucus

Page 34: LIVER DISEASES

FUNCTIONS Bile acts to some extent as a surfactant, helping to emulsify the fats in

the food. Since bile increases the absorption of fats, it is an important part of the

absorption of the fat-soluble vitamins, such as the vitamins D, E, K and A.

Bile serves also as the route of excretion for bilirubin, a by-product of red blood cells, recycled by the liver.

Bile salts also act as bactericides, destroying many of the microbes that may be present in the food.

Bile salt anions have a hydrophilic side and a hydrophobic side, and therefore tend to aggregate around droplets of fat (triglycerides and phospholipids) to form micelles, with the hydrophobic sides towards the fat and hydrophilic towards the outside.

Page 35: LIVER DISEASES

BILE SALTS have important Function in assisting the

digestive action of the pancreatic enzyme . helps in aiding the absorption of fats & fat

soluble vitamins form the small intestine. These salts by lowering the surface tension

cause fat droplets to break up or emulsify into small droplets allowing fat digesting enzyme to work more efficiently.

They convert them to fatty acids & glycerol ,the form in which they are absorbed.

Bile salts do not appear in faeces as they are reabsorbed from the small intestine & returned to the liver.

Page 36: LIVER DISEASES

BILE ACIDS These include 40% cholic acid . 40% chemodeoxycholic acid. 18% deooxycholic acid . 2% lithocholic acid. Total bile acid pool is 2.4 g but it is

absorbed & recirculated 6-8 times a day. Thus providing over 15- 20 gm of bile for digestion.

Page 37: LIVER DISEASES

BILE PIGMENTS Are derived from the breakdown of the

haemoglobin of worn out RBC’s & give the bile its characteristic color.

The bile pigments are converted in the bowel to urobilinogen by bacterial action.

Some urobilinogen is reabsorbed into the blood & is excreted by the kidneys into the urine.

Exposure of urine to the air causes urobilinogen to be oxidized to urobilin.

In the faeces , urobilinogen is altered 7 oxidized to form stercobilin which gives the faeces a dark brown colour.

If there is an obstruction to the excretion of bile , bile pigments accumulate in the blood giving the skin ,a yellow color (jaundice).

Page 38: LIVER DISEASES

BILE STORAGE The liver is constantly secreting bile, up

to 1 liter in a 24 hour period, but most of it is stored in the gallbladder.

This hollow organ can only hold 30 to 60 ml of bile and is able to store the large quantities of bile from the liver by concentrating it.

The gallbladder is able to achieve this by reabsorption of water, sodium, chloride and other electrolytes through its lining.

The other constituents of bile, like the bile salts, cholesterol, lecithin and bilirubin, stays in the gallbladder.

Page 39: LIVER DISEASES

BILE PRODUCTION The liver cells (hepatocytes) produce bile

which collects and drains into the hepatic duct.

From here it can enter the small intestine to act on fats by traveling down the common bile duct, or it can enter the gallbladder through the cystic duct, where it is stored.

The liver manufactures between 600ml to 1 liter of bile in a day. As bile travels down the ducts, the lining of these passages, secrete water, sodium and bicarbonate ions into the bile, thereby diluting it.

These additional substances help to neutralize the stomach acid which enters the duodenum with partially digested food (chyme) from the stomach.

Page 40: LIVER DISEASES

SECRETION & CIRCULATION OF BILE-`

Page 41: LIVER DISEASES

DISEASES

Cholelithiases

Page 42: LIVER DISEASES

CHOLELITHIASIS The formation of gallstones (calculi) in the absence of

infection of the gallbladder is called cholelithiasis. all gallstones form within the gallbladder Gallstones that pass from the gallbladder into the

common bile duct may remain there indefinitely without causing symptoms, or they may pass into the duodenum with or without symptoms.

Choledocholithiasis develops when stones slip into the bile ducts, producing obstruction, pain, and cramps.

If passage of bile into the duodenum is interrupted, cholecystitis can develop. In the absence of bile in the intestine, lipid absorption is impaired, and without bile pigments, stools become light in color.

If uncorrected, bile backup can result in jaundice and liver damage (secondary biliary cirrhosis).

Obstruction of the distal common bile duct can lead to pancreatitis if the pancreatic duct is blocked.

Page 43: LIVER DISEASES

TYPES OF STONES Most gallstones in people are unpigmented cholesterol

stones composed primarily of cholesterol ,bilirubin and calcium salts.

Risk factors for cholesterol stone formation include female gender, pregnancy, older age, family history obesity diabetes mellitus, inflammatory bowel disease and drugs (lipid-lowering medications, oral contraceptives and estrogens).

Rapid weight loss (as with jejunoileal and gastric bypass and fasting or severe calorie restriction) is associated with a high incidence of biliary sludge and gallstone formation .

Bacteria may also play a role in gallstone formation. Low-grade chronic infections produce changes in the gallbladder mucosa, which affect its absorptive capabilities. Excess water or bile acid may be absorbed as a result. Cholesterol may then precipitate out and cause gallstone formation .

Page 44: LIVER DISEASES

High dietary fat intake over a prolonged period may predispose a person to gallstone formation because of the constant stimulus to produce more cholesterol for bile synthesis required in fat digestion.

Pigmented stones typically consist of bilirubin polymers or calcium salts. They are associated with chronic hemolysis.

Risk factors associated with these stones are age, sickle cell anemia and thalassemia, biliary tract infection, cirrhosis, alcoholism and long-term PN( parenteral nutrition).

Page 45: LIVER DISEASES

MEDICAL MANAGEMENT treatment of gallstone disease includes

cholecystectomy, especially if the stones are numerous, large, or calcified.

cholecystectomy may be done as a traditional open laparotomy or as a less invasive laparoscopic procedure.

Chemical dissolution with the administration of bile salt with other acids are used but very less.

Patients with gallstones that have migrated into the bile ducts may be candidates for endoscopic retrograde cholangiopancreatography techniques

Page 46: LIVER DISEASES

NUTRITION THERAPY No specific dietary treatment is available to

prevent cholelithiasism in susceptible persons. Nutrition-related factors include obesity ,severe

fasting and these should be corrected when possible.

In cholecystitis, dietary treatment includes a low-fat diet to prevent gallbladder contractions.

After surgical removal of the gallbladder, oral feedings are usually resumed with the return of bowel movement.

after that the diet can be advanced to a regular diet as tolerated.

In the absence of the gallbladder, bile is secreted directly by the liver into the intestine.

Page 47: LIVER DISEASES

CHOLECYSTITIS Inflammation of the

gallbladder is known as cholecystitis.

it may be chronic or acute. It is usually caused by gallstones obstructing the bile ducts , leading to the backup of bile.

Bilirubin, the main bile pigment, gives bile its greenish color.

When biliary tract obstruction prevents bile from reaching the intestine, it backs up and returns to the circulation.

Page 48: LIVER DISEASES

ACUTE CHOLECYSTITIS Due to infection of gall bladder. It occurs in association with obstruction to

the cystic duct or neck of the gall bladder. Gall stones are the cause of obstruction The walls of the gallbladder become

inflamed and distended and infection can occur.

During such episodes, the patient experiences upper quadrant abdominal pain accompanied by nausea, vomiting, and flatulence.

Page 49: LIVER DISEASES

NUTRITIONAL THERAPY IN ACUTE CHOLECYSTITIS

In an acute attack, oral feedings are discontinued. Parenteral nutrition may be indicated if the patient is malnourished.

When feedings are resumed, a low-fat diet is recommended to decrease gallbladder stimulation

Patient should be kept in bed & given analgesics. Large quantities of fluids should be drunk. For acute cases, an entirely fluid of at least 2 -3

litres daily given in small feeds at hourly or two hourly intervals is advisable for few days.

Page 50: LIVER DISEASES

CHRONIC CHOLECYSTITIS Chronic cholecystitis is long-standing inflammation of

the gallbladder. It is caused by repeated mild attacks of acute

cholecystitis. This leads to thickening of the walls of the gallbladder. The gallbladder begins to shrink and eventually loses

the ability to perform its function: concentrating and storing bile.

Eating foods that are high in fat may aggravate the symptoms of cholecystitis because bile is needed to digest such foods.

Chronic cholecystitis occurs more often in women than in men and the incidence increases after the age of 40.

Risk factors include the presence of gallstones and a history of acute cholecystitis.

Page 51: LIVER DISEASES

NUTRITIONAL THERAPY IN CHRONIC CHOLECYSTITIS

Patients with chronic conditions may require a long-term low-fat diet that contains 25% to30% of total kilocalories as fat.

Stricter limitation is undesirable because fat in the intestine is important for some stimulation and drainage of the biliary tract.

The degree of food intolerance varies widely among persons with gallbladder disorders.

avoid foods that cause flatulence and bloating.

Page 52: LIVER DISEASES

CHOLESTASIS

Cholestasis is a condition in which little or no bile is secreted or the flow of bile into the digestive tract is obstructed.

This can occur in patients without oral or enteral feeding for a prolonged period and can predispose to a calculous cholecystitis.

Prevention includes stimulation of intestinal and biliary motility.

If this is not possible, drug therapy is used.

Page 53: LIVER DISEASES

DIAGNOSTIC TESTS Most common test is oral cholecystography. Presence of stones then can be visualized

by roentgenogram. When stones are not

visualized ,intravenous cholangiography is done. It involves administration of an iodine contrast dye

Injection of an iodine contrast medium permits visualization of biliary duct.

Ultrasonography & computed tomography (ct scan) can also be done.

Page 54: LIVER DISEASES

ACUTE CHOLANGITIS Pathophysiology and medical Management Inflammation of the bile ducts is known as

cholangitis. Patients with acute cholangitis need

resuscitation with fluids and broad-spectrum antibiotics.

If the patient does not improve with conservative treatment, placement of a percutaneous biliary stent or cholecystectomy may be done.

Page 55: LIVER DISEASES

SCLEROSING CHOLANGITIS Sclerosing cholangitis is another chronic

cholestatic liver disease. Fibrosing inflammation of segments of

extrahepatic bile ducts, with or without involvement of intrahepatic ducts.

Progression of the disease leads to complications of portal hypertension, hepatic failure and cholangiocarcinoma.

Primary Sclerosing cholangitis (PSC) is the most common type of Sclerosing cholangitis.

It usually occurs in association with inflammatory bowel disease.

Page 56: LIVER DISEASES

MEDICAL MANAGEMENT

Sclerosing cholangitis can result in sepsis and liver failure.

Most patients have multiple intrahepatic strictures, which makes surgical intervention difficult.

Patients are generally on broad-spectrum antibiotics.

When sepsis is recurrent, patients may require chronic antibiotic therapy.

Page 57: LIVER DISEASES

PANCREATIC DISEASES

Page 58: LIVER DISEASES

PANCREAS The pancreas is an

elongated, soft & flattened gland.

It lies in the upper abdomen behind the stomach.

It is 12-20 cm long in adults & weighing 75-85 gm.

The head of the pancreas is in the right upper quadrant below the stomach ,adjacent to the duodenum.

Page 59: LIVER DISEASES

Main pancreatic duct extends from tail, collecting it’s vital

secretions of enzymes.

This portion consists of about 1 million islets of langerhans, out

of which 80% secrete insulin, 15% secrete glucagon, 5% secrete

somatostatin. This glandular organ has both an endocrine & exocrine

function.

Page 60: LIVER DISEASES

FUNCTIONS The exocrine function is to secrete digestive

enzymes in the inactive form . Which only become activated after their release into

the pancreatic juices & the small intestine . the endocrine function is the secretion of insulin &

glucagon. Insulin is imp for the metabolism of CHO, fats &

proteins & glucagon is concerned with the breakdown of liver glycogen & with increased glucogenesis.

Page 61: LIVER DISEASES

TEST SIGNIFICANCE

SECRETIN STIMULATION TEST

MEASURES PANCREATIC SECREATION, PARTICULARLY BICARBONATE, IN RESPONSE TO SECRETIN STIMULATION.

GLUCOSE TOLERANCE TEST

ASSESES ENDOCRINE FUNCTION OF THE PANCREAS BY MEASURING INSULIN RESPONSE TO A GLUCOSE LEVEL.

72-HOUR STOOL FAT TEST

ASSESSES EXOCRINE FUNCTION OF THE PANCREAS BY MEASURING FAT ABSORPTION THAT REFLECTS PANCREATIC LIPASE SECRETION.

TESTS OF PANCREATIC FUNCTION

Page 62: LIVER DISEASES

PANCREATITIS Pancreatitis is an inflammation of the pancreas

and is characterized by oedema, cellular exudate and fat necrosis.

Pancreatitis is classified as either acute or chronic.

The symptoms of pancreatitis can range from continuous or intermittent pain of varying intensity to severe upper abdominal pain, which may radiate to the back.

Symptoms may worsen with the ingestion of food. Clinical presentation may also include nausea,

vomiting, abdominal distention, and steatorrhea. Severe cases are complicated by hypotension, oliguria, and dyspnea.

Page 63: LIVER DISEASES

Chronic Alcoholism

Gall stones

Biliary tract disease Trauma

Hypertriglyceridemia

hypercalcemiaCertain drugs

some viral infections

Pancreatitis

causes

Page 64: LIVER DISEASES

PATHOPHYSIOLOGYPancreatitis

Diagnosis •Test of pancreatic function

• Secretin stimulation test

• Glucose tolerance test• 72 hrs stool fat test

Clinical findings

Symptoms:• Abnormal pain and

distention• Nausea• Vomiting• Steatorrhea

In severe form:• Hypotension• Oliguria• dyspnea

Page 65: LIVER DISEASES

PANCREATITIS

NUTRITION MANAGEMENT

Acute:• Withhold oral and enternal feeding• If oral nutrition cannot be initiated in 5 to

7 days, start nutrition support• Once oral nutrition is started, provide:

• Easily digestible foods• Low fat diet• 6 small meals• Adequate protein intake• Increased calories

Chronic:• Provide oral diet as in acute phase• Supplement pancreatic enzymes• Supplement fat soluble vitamins and

vitamin B12

Acute:• Withhold oral feeding• Administer H2-receptor

antagonism, somatstatinChronic:• Manage intestinal pH with:

• Ant acids• H2 receptor inhibitors

• Administer insulin for glucose intolerance

MEDICAL MANAGEMENT

MANAGEMENT

Page 66: LIVER DISEASES

ACUTE PANCREATITIS This is a serious

disorder which may lead to haemorrhagic necrosis of the pancreas, peritonitis & death.

Biliary tract stone disease & alcohol abuse account for 80% of cases of acute pancreatitis.

Gall stones & biliary sludge impaires normal flow of secretion of pancreatic enzymes.

Severe acute pancreatitis results in a hyper metabolic & catabolic state.

Page 67: LIVER DISEASES

In these conditions, the effect of trypsin inhibitor may be overwhelmed.

if unchecked the rapidly activated enzymes literally digest the pancreas in few hours.

This phase is lethal & may lead to chronic pancreatic insufficiency.

Genetic disease like cystic fibrosis may also lead to pancreatic insufficiency.

Page 68: LIVER DISEASES

CHRONIC PANCREATITIS Alcohol & malnutrition are the major causes of chronic

pancreatitis. It is characterized by recurrent attacks of, epigastric pain of long

duration that may radiate into the back. The pain can be precipitated by meals. The gastric pain is associated with nausea, vomiting or diarrhea. Rarely, chronic pancreatitis is hereditary. Principle sign of chronic pancreatitis is malabsorption caused by

deficiency of pancreatic enzymes& subsequent steatorrhoea.

Page 69: LIVER DISEASES

OBJECTIVE OF THERAPY to prevent further damage to the pancreas. decrease the number of attacks of acute

inflammation, alleviate pain, decrease steatorrhea, and correct malnutrition.

Dietary intake should be as liberal as possible, but modifications may be necessary to minimize symptoms

Substitution of dietary fat with MCT oil may relieve steatorrhea and lead to weight gain.

Antacids, H2-receptor antagonists that reduce gastric acid secretion may be used to

achieve this effect.